Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 251,102 | 95,565 | 238,947 | 173,688 | 186,426 |
| Marketable Securities | 155,427 | 92,198 | 71,601 | N/A | N/A |
| Receivables | 211,328 | 228,540 | 179,525 | 183,119 | 105,844 |
| Inventories | 40,912 | 35,560 | 32,332 | 46,501 | 17,394 |
| TOTAL | $691,411 | $482,257 | $537,600 | $419,989 | $315,543 |
| Non-Current Assets | |||||
| PPE Net | 12,013 | 14,329 | 15,983 | 19,521 | 19,491 |
| Intangibles | 815,435 | 1,053,735 | 555,565 | 701,163 | 268,723 |
| Other Non-Current Assets | 137,975 | 113,270 | 34,160 | 33,458 | 88,320 |
| TOTAL | $965,423 | $1,181,334 | $605,708 | $754,142 | $376,534 |
| Total Assets | $1,656,834 | $1,663,591 | $1,143,308 | $1,174,131 | $692,077 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29,000 | 64,583 | 183,333 | 162,500 | 48,353 |
| Accounts payable and accrued liabilities | 10,659 | 3,934 | 8,692 | 3,494 | 4,189 |
| Accrued Expenses | 380,730 | 410,766 | 264,902 | 266,620 | 226,210 |
| Other current liabilities | 17,565 | 28,956 | N/A | N/A | N/A |
| TOTAL | $440,028 | $509,510 | $457,915 | $433,726 | $279,566 |
| Non-Current Liabilities | |||||
| Long Term Debt | 542,112 | 550,733 | 221,713 | 397,578 | 61,666 |
| Deferred Revenues | 667 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 363,908 | 364,506 | 268,249 | 147,985 | 147,917 |
| TOTAL | $915,131 | $925,239 | $489,962 | $545,563 | $209,583 |
| Total Liabilities | $1,355,159 | $1,434,749 | $947,877 | $979,289 | $489,149 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,753 | 31,486 | 31,960 | 34,067 | 33,378 |
| Common Shares | 41 | 40 | 38 | 37 | 36 |
| Retained earnings | -101,129 | -163,999 | -233,189 | -281,344 | -256,342 |
| Other shareholders' equity | 809 | 550 | -367 | 76 | 139 |
| TOTAL | $301,675 | $228,842 | $195,431 | $194,842 | $202,928 |
| Total Liabilities And Equity | $1,656,834 | $1,663,591 | $1,143,308 | $1,174,131 | $692,077 |